Biosquare Biotechnologies India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-12-2024
- Paid Up Capital ₹ 1.80 M
as on 29-12-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
as on 29-12-2024
- Satisfied Charges ₹ 6.30 M
as on 29-12-2024
- Revenue -26.45%
(FY 2023)
- Profit -53.51%
(FY 2023)
- Ebitda -26.23%
(FY 2023)
- Net Worth 10.52%
(FY 2023)
- Total Assets 11.65%
(FY 2023)
About Biosquare Biotechnologies India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹0.40 M. The company has closed loans amounting to ₹6.30 M, as per Ministry of Corporate Affairs (MCA) records.
Lokireddy Reddy and Suneetha Lokireddy serve as directors at the Company.
- CIN/LLPIN
U51909TG2011PTC074803
- Company No.
074803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2011
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biosquare Biotechnologies India Private Limited offer?
Biosquare Biotechnologies India Private Limited offers a wide range of products and services, including Geotextile, Geogrids & Pond Liners, Water Resistant Membranes, Chemical Reagents & Catalysts, Bio Chemicals, Plastic & Glass Labware, Laboratory Plates, Medical Laboratory Instruments, PCR Machine, Laboratory Plasticware.
Who are the key members and board of directors at Biosquare Biotechnologies India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lokireddy Reddy  | Director | 02-Jun-2011 | Current |
| Suneetha Lokireddy | Director | 24-Mar-2014 | Current |
Financial Performance of Biosquare Biotechnologies India.
Biosquare Biotechnologies India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.45% decrease. The company also saw a substantial fall in profitability, with a 53.51% decrease in profit. The company's net worth Soared by an impressive increase of 10.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosquare Biotechnologies India?
Unlock access to Biosquare Biotechnologies India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Oct 2019 | ₹0.40 M | Open |
Others Creation Date: 22 Nov 2016 | ₹1.00 M | Satisfied |
Hdfc Bank Limited Creation Date: 27 Jan 2016 | ₹3.50 M | Satisfied |
How Many Employees Work at Biosquare Biotechnologies India?
Unlock and access historical data on people associated with Biosquare Biotechnologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosquare Biotechnologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosquare Biotechnologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
